Our data indicate that MRP8 in myeloid cells could potentially aggravate glomerular injury through intraglomerular cell-cell crosstalk affecting Mφ characterization, suggesting the suppression of MRP8 as a potential therapeutic target to ameliorate crescentic glomerulonephritis. The gene discussed is S100A8; the disease is crescentic glomerulonephritis.